Cardiol Therapeutics Inc Class A
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -33 | |||
EBITDA | -9,938 | -7,650 | -8,404 | -5,649 |
EBIT | -9,964 | -7,676 | -8,429 | -5,683 |
Net Income | -9,964 | -8,354 | -8,287 | -5,683 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,928 | -4,557 | -7,165 | -5,599 |
Cash | 11,622 | 18,195 | 23,292 | 30,580 |
Basic Shares | 84,727 | 82,653 | 82,608 | 69,841 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $62 |
Gross Profit | -187 | -162 | -111 | |
EBITDA | -40,114 | -21,035 | -22,655 | -24,838 |
EBIT | -40,276 | -21,222 | -22,817 | -25,013 |
Net Income | -36,677 | -21,222 | -22,817 | -25,013 |
Net Change In Cash | 0 | 0 | 0 | 62 |
Free Cash Flow | -25,082 | -25,244 | -27,295 | -23,563 |
Cash | 30,580 | 34,931 | 43,825 | 83,899 |
Basic Shares | 71,567 | 64,463 | 62,505 | 43,222 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.08 |
2025-06-30 | -$0.07 |
2025-03-31 | -$0.10 |
